-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NUhBb+Mh0HTT/x4E+oHbOMBrkvun9LlxNoMl/QiFAt0pBHFczykcTDLFc2EpBlW+ OKxOM489ax2kgTBbrGuQVg== 0001013708-96-000036.txt : 19960813 0001013708-96-000036.hdr.sgml : 19960813 ACCESSION NUMBER: 0001013708-96-000036 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960630 FILED AS OF DATE: 19960812 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIZONE INTERNATIONAL INC CENTRAL INDEX KEY: 0000753772 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 870412648 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 002-93277-D FILM NUMBER: 96608747 BUSINESS ADDRESS: STREET 1: 123 E 54TH ST #2H CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2124210303 FORMER COMPANY: FORMER CONFORMED NAME: MADISON FUNDING INC DATE OF NAME CHANGE: 19860413 NT 10-K 1 NOTIFICATION OF LATE FILING U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING | | Form 10-K and Form 10-KSB | | Form 20-F | | Form 11-K |X| Form 10-Q and Form 10-QSB | | Form N-SAR For Period Ended: June 30, 1996 | | Transition Report on Form 10-K | | Transition Report on Form 20-F | | Transition Report on Form 11-K | | Transition Report on Form 10-Q | | Transition Report on Form N-SAR For the Transition Period Ended:------------------------------------------- - -------------------------------------------------------------------------------- If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: ------------------ Item 8, Part II, Financial Statements. - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- Part I - Registrant Information - -------------------------------------------------------------------------------- Full Name of Registrant: Medizone International, Inc. Former Name if Applicable: (originally, Madison Funding, Inc.) 123 East 54th Street --------------------------------------------------------------------------- Address of Principal Executive Office (Street and Number) New York, New York 10022 --------------------------------------------------------------------------- City, State and Zip Code - -------------------------------------------------------------------------------- Part II - Rules 12b-25(b) and (c) - -------------------------------------------------------------------------------- If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b) the following should be completed. (Check box if appropriate). |X| (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; | | (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and | | (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. - -------------------------------------------------------------------------------- Part III - Narrative - -------------------------------------------------------------------------------- Certain of the financial information required to be included in the registrant's quarterly report on Form 10-Q for the period ended June 30, 1996 could not be obtained in a timely manner without the unreasonable expense and effort on the part of the registrant. - -------------------------------------------------------------------------------- Part IV - Other Information - -------------------------------------------------------------------------------- (1) Name and telephone number of person to contact in regard to this notification Andrew E. Goldstein, Esq. (212) 826-2000 - -------------------------------------------------------------------------------- (Name) (Area Code)(Telephone Number) (2) Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). |X| Yes | | No (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? | | Yes |X| No If so; attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. Medizone International, Inc. - -------------------------------------------------------------------------------- (Name of Registrant as specific in charter) has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized. Date: August 14, 1996 --------------- By /s/Arthur P. Bergeron -------------------------------------- Arthur P. Bergeron, Vice President, Treasurer and Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----